YTHDC2 and neoplasm: Yet, YTHDC2 was positively associated with tumour purity in 10 cancer types, such as BRCA, SKCM, SKCM‐primary, glioblastoma multiforme (GBM), BRCA‐Luminal, BLCA, Sarcoma (SARC), TGCT, LGG and ACC (Figure S6).